10 news items
Unveiling 5 Analyst Insights On Baxter Intl
BAX
30 May 24
Analysts have set 12-month price targets for Baxter Intl, revealing an average target of $40.6, a high estimate of $45.00, and a low
Goldman Sachs Initiates Coverage On Baxter Intl with Neutral Rating, Announces Price Target of $36
BAX
30 May 24
Goldman Sachs analyst David Roman initiates coverage on Baxter Intl (NYSE:BAX) with a Neutral rating and announces Price Target of $36.
New Cohort Study Data Shows Baxter's Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
BAX
29 May 24
targets the efficient removal of large-middle molecules,1,2,3,4 allowing for filtration closer
Citigroup Maintains Neutral on Baxter Intl, Lowers Price Target to $38
BAX
22 May 24
Citigroup analyst Joanne Wuensch maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $44 to $38.
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
BAX
DVA
FMS
17 May 24
targets. However, recent performance improvements suggest a potential turnaround for the dialysis specialist.
Michael Sen
jg8xxpov0mluvwlmjl41k ccva4yyfofvzb7jeywp32b
BAX
10 May 24
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $45.75, along with a high estimate
t9yv32iwipojzmbk3k3nm0mc62j6e2w8mslwa94klxt2jcg7c4y4udm
BAX
10 May 24
TD Cowen analyst Joshua Jennings downgrades Baxter Intl (NYSE:BAX) from Buy to Hold and announces $40 price target.
y9grp7b1ahqu9c2xpximlil3d1kfhp3w3ok92wm071ev8njuh6
APTX
BAX
23 Apr 24
Biotherapeutics: Tentarix's mission is to develop first-in-class targeted, multifunctional, conditional therapies across a range of indications of high
6nwwt1s3s 9t53m5vvl8jbjs6vk9oven8
BAX
3 Apr 24
0
Analysts have recently evaluated Baxter Intl and provided 12-month price targets. The average target
5qfu6yrsvn8rxi3ggnrysaz3c8
BAX
3 Apr 24
Citigroup analyst Joanne Wuensch maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $41 to $44.
- Prev
- 1
- Next